These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 649233)

  • 41. Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin.
    Lode H; Kemmerich B; Koeppe P
    Antimicrob Agents Chemother; 1975 Oct; 8(4):396-401. PubMed ID: 1103722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of the minimum inhibitory concentrations of sisomicin and of fourteen other antibiotics.
    Pitzus E; Ghinelli P; Turano A; Romano F; Cadenelli GP
    J Int Med Res; 1978; 6(5):414-7. PubMed ID: 359385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Studies on the combination action of sisomicin, gentamicin and cefmenoxime, ceftizoxime, cefoperazone, cefotetan against Serratia marcescens and Pseudomonas aeruginosa].
    Kubo M; Kato Y; Inamori Y
    Jpn J Antibiot; 1985 Dec; 38(12):3487-96. PubMed ID: 3938819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague].
    Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV
    Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 5-epi-Sisomicin and 5-epi-Gentamicin B: substrates for aminoglycoside-modifying enzymes that retain activity against aminoglycoside-resistant bacteria.
    Vastola AP; Altschaefl J; Harford S
    Antimicrob Agents Chemother; 1980 May; 17(5):798-802. PubMed ID: 6967296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats.
    Fabre J; Rudhardt M; Blanchard P; Regamey C
    Kidney Int; 1976 Dec; 10(6):444-9. PubMed ID: 1011538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sisomicin in surgical infections. Laboratory and clinical studies.
    Perea EJ; Gutierrez de la Pena C; Oliver DA; Solorzano G; Garcia-Diaz S
    Arzneimittelforschung; 1979; 29(1):134-7. PubMed ID: 375945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic study of sisomicin in humans.
    Chung M; Schrogie JJ; Symchowicz S
    J Pharmacokinet Biopharm; 1981 Oct; 9(5):535-51. PubMed ID: 7334458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.
    Haller I
    Infection; 1982; 10 Suppl 3():S229-33. PubMed ID: 6818155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetic investigations on sisomicin in children (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter J
    Monatsschr Kinderheilkd (1902); 1978 Aug; 126(8):512-7. PubMed ID: 683201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the antibiotic activities of sisomicin, gentamicin and aminosidine sulphate against pseudomonas aeruginosa.
    Pitzus E; Ghinelli P; Turano A; Romano F; Cadenelli GP
    J Int Med Res; 1978; 6(5):418-9. PubMed ID: 100354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sisomicin pharmacokinetics after a single intravenous dose].
    Lypka A; Orłowski T; Lazowski J; Wierzba K
    Wiad Lek; 1979 Sep; 32(17):1223-8. PubMed ID: 506260
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical pharmacology of sisomicin.
    Rodriguez V; Bodey GP; Valdivieso M; Feld R
    Antimicrob Agents Chemother; 1975 Jan; 7(1):38-41. PubMed ID: 1137357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pharmacokinetics of a cefotetan and an aminoglycoside preparation in combined administration. 2. Absorption and exercise of cefotetan and sisomicin in dogs when the two are given together].
    Ikeda C; Tachibana A; Yano K
    Jpn J Antibiot; 1982 Jun; 35(6):1427-36. PubMed ID: 6957628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Experience with sisomicin in pediatrics (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Burchardt U; Richter I
    Infection; 1979; 7(3):119-27. PubMed ID: 383623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Quantitative indicators of gentamicin and sisomicin interaction with isolated subcellular fractions of the liver and kidneys and intracellular distribution of these antibiotics].
    Guliaev AE; Kivman GIa
    Antibiot Med Biotekhnol; 1985 Jan; 30(1):50-4. PubMed ID: 3994342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pharmacokinetics of lividomycin, aminkacin and sisomicin in patients with chronic renal insufficiency].
    Leroy A; Oksenhendler G; Fillastre JP; Humbert G
    J Urol Nephrol (Paris); 1977 Sep; 83(9):738-41. PubMed ID: 243544
    [No Abstract]   [Full Text] [Related]  

  • 58. [A pharmacokinetic investigation of sisomicin administered intramuscularly to children].
    Nishimura T; Iwai N; Motohiro T
    Jpn J Antibiot; 1984 May; 37(5):835-46. PubMed ID: 6481958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy, tolerance, and pharmacokinetics of sisomicin in urinary tract infections (author's transl)].
    Dobbelstein H; Isbary E; Lang W
    Infection; 1978; 6(6):271-6. PubMed ID: 103844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical pharmacology of netilmicin.
    Yap BS; Stewart D; Bodey GP
    Antimicrob Agents Chemother; 1977 Dec; 12(6):717-20. PubMed ID: 931370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.